MENU
RGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Repligen (RGEN) Ownership - Who owns Repligen?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
10.26B
P/E Ratio
247.52
Total Cash
751.32M
Projected Growth
N/A
Total Debt
711.8M
Revenue
638.76M
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash/Share
13.47
Total Debt/Equity
N/A
Revenue/Share
11.33 USD as % of share price
Fundamentals
RGEN
Capitalization
10.3B
P/E Ratio
247.52
Risk (Beta)
1.21
Dividend Yield
N/A
Total Cash
751M
Total Cash/Share
13.47
Total Debt
712M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
11.33%
Revenue
639M
ROE
N/A
Book Value
1.97B
P/B Ratio
5.18
Cash Flow
N/A
Earnings
0.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
558K
Current Ratio
7.02
Current Revenue Per Employee
87348.85
Dividends Per Share - Security
N/A
EBITDA
134M
Float
N/A
Float - Current
N/A
Gross Income Margin
43.41
Revenue To Assets
1.55
Shares Held By Institutions
20.1B
Shares Outstanding - Current
55.8M
Total Liabilities
853M
Total Volume MTD
N/A
Value
-1
Gain YTD
-19.655
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biologic drugs
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com